Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
This study has been completed.
Study NCT00061529   Information provided by Alcon Research

First Received on May 28, 2003.   Last Updated on August 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Open-Angle Glaucoma
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Glaucoma, Open-Angle
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Brimonidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Alcon Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services